Diabetes Mellitus and Hypertension: Key Risk Factors for Kidney Disease

Total Page:16

File Type:pdf, Size:1020Kb

Diabetes Mellitus and Hypertension: Key Risk Factors for Kidney Disease DIABETES MELLITUS AND HYPERTENSION: KEY RISK FACTORS FOR KIDNEY DISEASE Janice P. Lea, MD, and Susanne B. Nicholas, MD, PhD Atlanta, Georgia, and Los Angeles, California The incidence of end-stage renal disease (ESRD) in the US is rising at an alarming rate, with the largest increase among African-American populations. The key risk factors for kidney disease are hypertension and diabetes, which are both becoming more prevalent in the US, and particu- larly in African Americans. Although African Americans make up 12.6% of the US population, the incidence of diabetes-related ESRD is four times higher than for whites, and the prevalence of ESRD due to hypertension is twice that of white patients. Approximately 30 to 40% of all patients with diabetes will develop nephropathy and many will progress to ESRD, necessitating dialysis or kidney transplantation. Recent studies in patients with type 2 diabetes indicate a significant delay in progression or development of diabetic nephropathy following blockade of the renin- angiotensin-aldosterone system with the use of angiotensin receptor antagonists. Early intervention in patients with hypertension is necessary to prevent kidney damage, and data from the African American Study of Kidney Disease and Hypertension suggest that angiotensin- converting enzyme inhibitors are effective in this population. Although African-American patients receiving hemodialysis appear to have increased survival compared with whites, racial factors and poor access to medical care contribute to the increased risk of kidney disease in minorities. A con- certed effort is necessary to raise awareness in minority populations and provide strategies for prevention and early treatment thereby attenuating the increasing prevalence of kidney failure in these groups. Key words: end-stage renal disease * next 10 years.5 In general, the most common diabetes + hypertension + kidney disease causes of ESRD are diabetes and hypertension (Fig. 1).5 Chronic kidney disease (CKD) and end-stage A major risk factor for the development oftype renal disease (ESRD) affect an increasing pro- 2 diabetes is obesity.6 Therefore, it is thought that portion of the population in the US. 1-3 The Third the dramatic increase in the incidence of ESRD National Health and Nutrition Examination that has been observed over the past 20 years is Survey (NHANES III) recently estimated the attributable to the epidemic of type 2 diabetes that prevalence of CKD (defined as a serum creatinine has occurred during this time. At present, approxi- level of > 1.5 mg/dL) in the US to be approxi- mately 15.6 million Americans have diabetes, pre- mately 6.2 million,4 and the number of patients dominantly type 2 diabetes. A further 13.4 million with ESRD is expected to almost double in the have impaired glucose tolerance,7 and 50 million have hypertension.8 However, the prevalence of © 2002. From Emory University School of Medicine, Atlanta, Georgia; and the University of California School of Medicine, Los diabetes, hypertension, and obesity is significantly Angeles, California. Address correspondence to: Janice R Lea, higher in African Americans than in whites, MD, Assistant Professor of Medicine, Department of Medicine, particularly in the Southeastern region of the US. Emory University School of Medicine, Woodruff Memorial Building, Atlanta, GA 30322; phone (404) 727-2521; fax (404) In fact, the prevalence of hypertension in African 727-3425; or direct e-mail to [email protected]. Americans is among the highest in the world.9 JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION VOL. 94, NO. 8 (SUPPL), AUGUST 2002 7S KEY RISK FACTORS FOR KIDNEY DISEASE (IDNT) studies have reported the effect of 100 angiotensin receptor antagonism on delaying the 90 progression and development of diabetic nephropathy in hypertensive type 2 diabetics. 80 These studies were performed in large populations with representative (A14%) African-American - 70 enrollment.15,16 These studies have demonstrated C 60 that blockade of the RAAS via angiotensin recep- 50.1 tor blockade can also improve BP, and attenuate a g 50 rise in serum creatinine levels and the time to ESRD. However, the lessons learned from these j40. latter studies can only be useful if patients are 30 27 monitored aggressively, not only for BP and blood glucose, but also for early detection of proteinuria 20 and deterioration in kidney function. 10 This review will focus on the two main caus- es of the increase in the prevalence of ESRD, 0 diabetes and hypertension. It will also discuss Diabetes Hypertewon reasons for disparities between populations, highlight risk factors in the post-transplant per- iod, explore factors contributing to suboptimal Figure 1. Primary Causes of ESRD.5 care in these patients, and propose steps to Data from US Renal Data System 2000. address these issues. As a result, the adjusted incidence ofESRD among REASONS FOR RACIAL DISPARITIES African Americans in the Southeastern US has IN KIDNEY DISEASE been estimated to be up to 15-fold greater than Demographic data suggest that those most in whites.10 In addition, even when hypertension susceptible to ESRD are the elderly (> 65 years is well-controlled, there is a tendency for African of age), those of low socioeconomic status, Americans to suffer impairments in kidney and minority groups, particularly African function.1 1,12 Americans.10 In addition, data from the Multiple Recently, the African-American Study of Risk Factor Intervention Trial (MRFIT) and Kidney Disease and Hypertension (AASK) exam- Modification of Diet in Renal Disease (MDRD) ined the role of the renin-angiotensin-aldosterone study suggest a significantly greater rate of loss system (RAAS) and the use of angiotensin- of kidney function in African Americans with converting enzyme (ACE) inhibitors in the hypertension compared with whites. 12,17,18 Taken management of hypertension, specifically in together, these data suggest that African African Americans.13 Preliminary findings have Americans possess a unique susceptibility to demonstrated that ACE inhibitor therapy can effec- kidney disease. tively improve blood pressure (BP) and signifi- A complex interplay of genetic, cultural, cantly reduce the rate of rise of serum creatinine social and environmental influences, as well as levels and time to ESRD. 14 In addition, the healthcare inequities, play a part in the racial Reduction of Endpoints in NIDDM with the disparities associated with kidney disease.1 9-21 Angiotensin II Antagonist Losartan (RENAAL) Diets high in calories, carbohydrates, and and Irbesartan Type II Diabetic Nephropathy Trial sodium, but low in potassium, magnesium, and 8S JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION VOL. 94, NO. 8 (SUPPL), AUGUST 2002 KEY RISK FACTORS FOR KIDNEY DISEASE calcium, are common in minority populations, Pathogenesis of Diabetic and may contribute to the higher prevalence and Kidney Disease severity of hypertension among African Early in the course of diabetic nephropathy, Americans compared with whites.22 African- changes in kidney hemodynamics and hyperfiltra- American patients with hypertension have higher tion lead to an increase in glomerular filtration rate rates of salt sensitivity, and recent evidence sug- (GFR).26 The progression of nephropathy involves gests that this causes higher rates of left ventricu- characteristic pathologic changes, including accu- lar hypertrophy, higher serum creatinine levels, mulation of the extracellular matrix, widening of and increased urinary albumin excretion, as well the glomerular basement membrane, arteriosclero- as retinopathy.23 High sodium diets increase sis, and some degree of interstitial fibrosis.27 To BP,24 and so raise intraglomerular pressure in date, there is no evidence of any significant differ- salt-sensitive patients, which may contribute to ence in the histologic changes that occur in African the propensity for kidney failure in African Americans and whites. Americans. How sodium sensitivity increases the The earliest clinical manifestation of diabetic risk of cardiovascular events remains unknown, nephropathy is microalbuminuria (20 to 200 but it may be due to concurrent microalbumin- ,ug/min), which, if left untreated, can progress to uria. Clustering of several factors with well- overt nephropathy after 10 to 15 years of diabetes, known atherogenic potential, including hyper- and is also a marker for cardiovascular disease.27 insulinemia, hyperlipidemia, and microalbumin- In African Americans, albuminuria may be present in 30 to 40% of with uria, in salt-sensitive hypertensive patients patients diabetic nephro- may pathy.28,29 However, delayed diagnosis and poorer explain, in part, their increased risk of cardiovas- control of plasma glucose and BP among African- cular disease. In fact, this metabolic syndrome, American patients reduce the chances of improve- also termed syndrome X, is associated with ment and resolution of microalbuminuria. Some of obesity and type 2 diabetes, and may be more the clinical features that are characteristic oftype 2 prevalent in African Americans.25 diabetic nephropathy are listed in Table 1. In fact, the increasing racial disparities in Although, poor glycemic control and hyper- diabetic nephropathy in African Americans may tension are the major risk factors in African be directly related to the increased incidence of Americans that contribute to a more rapid pro- obesity, particularly in African-American females gression to ESRD, other putative risk factors who demonstrate the highest prevalence,
Recommended publications
  • Diabetes Is a Disease in Which the Body's Ability to Produce Or Respond
    Early Signs and Symptoms of diabetes: Early symptoms of diabetes, especially type 2 diabetes, can be subtle or seemingly harmless. Over time, however, you may Diabetes is a disease in which the develop diabetes complications, even if you body’s ability to produce or respond to haven't had diabetes symptoms. In the the hormone insulin is impaired, United States alone, more than 8 million resulting in abnormal metabolism of people have undiagnosed diabetes, Treatments: carbohydrates and elevated levels of according to the American Diabetes Association. Understanding possible glucose (sugar) in the blood. • Insulin therapy diabetes symptoms can lead to early • Oral medications diagnosis and treatment and a lifetime of Diabetes can be broken down into • better health. If you're experiencing any of Diet changes two types, Type 1 and Type 2. Type 1 • Exercise diabetes involves the the following diabetes signs and symptoms, see your doctor. body attacking itself by The medications you take vary by mistake, this then the type of diabetes and how well the causes the body to stop making insulin. With medicine controls you blood glucose levels. Type 2 diabetes the Type 1 diabetics must have insulin. Type 2 body does not respond may or may not include insulin and may just like it should to the be controlled with diet and exercise alone. insulin the pancreas is If you notice any of these changes notify making. Your body tells the pancreas that it needs to make more insulin since the your health care provider. The earlier • insulin that is already there is not working.
    [Show full text]
  • Prediabetes: What Is It and What Can I Do?
    Prediabetes: What Is It and What Can I Do? What is prediabetes? Weight loss can delay or prevent diabetes. Prediabetes is a condition that comes before Reaching a healthy weight can help you a lot. diabetes. It means your blood glucose levels are If you’re overweight, any weight loss, even higher than normal but aren’t high enough to be 7 percent of your weight (for example, losing called diabetes. about 15 pounds if you weigh 200), may lower your risk for diabetes. There are no clear symptoms of prediabetes. You can have it and not know it. If I have prediabetes, what does it mean? It means you might get type 2 diabetes soon or down the road. You are also more likely to get heart disease or have a stroke. The good news is that you can take steps to delay or prevent type 2 diabetes. How can I delay or prevent type 2 diabetes? You may be able to delay or prevent type 2 diabetes with: Daily physical activity, such as walking. Weight loss, if needed. Losing even a few pounds will help. Medication, if your doctor prescribes it. If you have prediabetes, these steps may bring your blood glucose to a normal range. But you are still at a higher risk for type 2 diabetes. Regular physical activity can delay or prevent diabetes. Being active is one of the best ways to delay or prevent type 2 diabetes. It can also lower your weight and blood pressure, and improve cholesterol levels. Ask your health care team about activities that are safe for you.
    [Show full text]
  • Low Blood Glucose (Hypoglycemia)
    Low Blood Glucose (Hypoglycemia) Hypoglycemia, also known as low blood Hunger, nausea glucose (blood sugar), is when your blood Color draining from skin (pallor) glucose levels have fallen low enough that you need to take action to bring them back Feeling sleepy to your target range. This is usually when your blood glucose is less than 70 mg/dL. However, Feeling weak, having no energy talk to your doctor about your own blood Blurred/impaired vision glucose targets, and what level is too low for you. Tingling or numbness in lips, tongue, cheeks Headaches When can it happen? Coordination problems, clumsiness Low blood glucose can happen if you’ve skipped a meal or snack, eaten less than usual, or been Nightmares or crying out in sleep more physically active than usual. If you don’t Seizures take steps to bring glucose levels back to normal, you could even pass out. What should you do? What are the symptoms? The 15-15 rule—have 15 grams of carbohydrate to raise your blood glucose and check it after Each person’s reaction to low blood glucose is 15 minutes. If it’s still below 70 mg/dL, have different. It’s important that you learn your own another serving. signs and symptoms when your blood glucose is low. Repeat these steps until your blood glucose is at least 70 mg/dL. Once your blood glucose is back Signs and to normal, eat a meal or snack to make sure it symptoms of doesn’t lower again. low blood glucose include: This may be: Feeling shaky Glucose tablets (see instructions) Being nervous Gel tube (see instructions) or anxious 4 ounces (1/2 cups) of juice or regular soda Sweating, chills, (not diet) clamminess 1 tablespoon of sugar, honey, or corn syrup Mood swings, irritability, impatience 8 ounces of nonfat or 1% milk Confusion Hard candies, jellybeans, or gumdrops—see Fast heartbeat food label for how many to consume Feeling light-headed or dizzy Continued » Visit diabetes.org or call 800-DIABETES (800-342-2383) for more resources from the American Diabetes Association.
    [Show full text]
  • Diabetic Ketoacidosis: Evaluation and Treatment DYANNE P
    Diabetic Ketoacidosis: Evaluation and Treatment DYANNE P. WESTERBERG, DO, Cooper Medical School of Rowan University, Camden, New Jersey Diabetic ketoacidosis is characterized by a serum glucose level greater than 250 mg per dL, a pH less than 7.3, a serum bicarbonate level less than 18 mEq per L, an elevated serum ketone level, and dehydration. Insulin deficiency is the main precipitating factor. Diabetic ketoacidosis can occur in persons of all ages, with 14 percent of cases occurring in persons older than 70 years, 23 percent in persons 51 to 70 years of age, 27 percent in persons 30 to 50 years of age, and 36 percent in persons younger than 30 years. The case fatality rate is 1 to 5 percent. About one-third of all cases are in persons without a history of diabetes mellitus. Common symptoms include polyuria with polydipsia (98 percent), weight loss (81 percent), fatigue (62 percent), dyspnea (57 percent), vomiting (46 percent), preceding febrile illness (40 percent), abdominal pain (32 percent), and polyphagia (23 percent). Measurement of A1C, blood urea nitro- gen, creatinine, serum glucose, electrolytes, pH, and serum ketones; complete blood count; urinalysis; electrocar- diography; and calculation of anion gap and osmolar gap can differentiate diabetic ketoacidosis from hyperosmolar hyperglycemic state, gastroenteritis, starvation ketosis, and other metabolic syndromes, and can assist in diagnosing comorbid conditions. Appropriate treatment includes administering intravenous fluids and insulin, and monitoring glucose and electrolyte levels. Cerebral edema is a rare but severe complication that occurs predominantly in chil- dren. Physicians should recognize the signs of diabetic ketoacidosis for prompt diagnosis, and identify early symp- toms to prevent it.
    [Show full text]
  • Diabetic Ketoacidosis Diabetic Ketoacidosis (DKA) Is a Serious Problem That Can Happen in People with Diabetes
    Diabetic Ketoacidosis Diabetic ketoacidosis (DKA) is a serious problem that can happen in people with diabetes. DKA should be treated as a medical emergency. This is because it can lead to coma or death. If you have the symptoms of DKA, get medical help right away. DKA happens more often in people with type 1 diabetes. But it can happen in people with type 2 diabetes. It can also happen in women with diabetes during pregnancy (gestational diabetes). DKA happens when insulin levels are too low. Without enough insulin, sugar (glucose) can’t get to the cells of your body. The glucose stays in the blood. The liver then puts out even more glucose into the blood. This causes high blood glucose (hyperglycemia). Without glucose, your body breaks down stored fat for energy. When this happens, acids called ketones are released into the blood. This is called ketosis. High levels of ketones (ketoacidosis) can be harmful to you. Hyperglycemia and ketoacidosis can also cause serious problems in the blood and your body, such as: • Low levels of potassium (hypokalemia) and phosphate • Damage to kidneys or other organs • Coma What causes diabetic ketoacidosis? In people with diabetes, DKA is most often caused by too little insulin in the body. It is also caused by: • Poor management of diabetes • Infections such as a urinary tract infection or pneumonia • Serious health problems, such as a heart attack • Reactions to certain prescribed medicines including SGLT2 inhibitors for treating type 2 diabetes • Reactions to illegal drugs including cocaine • Disruption of insulin delivery from an insulin pump Symptoms of diabetic ketoacidosis DKA most often happens slowly over time.
    [Show full text]
  • Am I at Risk for Gestational Diabetes?
    Am I at risk for gestational diabetes? U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Eunice Kennedy Shriver National Institute of Child Health and Human Development What is gestational diabetes? Gestational diabetes (pronounced jess-TAY-shun-ul die-uh-BEET-eez) is a type of high blood sugar that only pregnant women get. In fact, the word “gestational” means pregnant. If a woman gets high blood sugar when she’s pregnant, but she never had high blood sugar before, she has gestational diabetes. Between 2 percent and 10 percent of U.S. pregnancies are affected by the condition every year,1 making it one of the top health concerns related to pregnancy. If not treated, gestational diabetes can cause problems for mothers and babies, some of them serious. But there is good news. Most of the time, gestational diabetes goes away after the baby is born. The changes in your body that cause gestational diabetes normally occur only when you are pregnant. After the baby is born, your body goes back to normal and the condition goes away. Gestational diabetes is treatable, and the best outcomes result from careful management and control of blood sugar levels. The best way to control gestational diabetes is to find out you have it early and start treatment quickly. Treating gestational diabetes—even if you don’t have any symptoms or your symptoms are mild— greatly reduces health problems for mother and baby. Why do some women get gestational diabetes? Usually, the body breaks down much of the food you eat into a type of sugar, called glucose (pronounced GLOO-kos).
    [Show full text]
  • Fructosamine Interpretive Summary
    Fructosamine Interpretive Summary Description: Fructosamine is a complex of glucose and protein that can be used to assess the average blood glucose concentration in a dog or cat over the previous 2-3 weeks. It is used in the diagnosis and management of diabetes mellitus. Decreased Fructosamine Common Causes Prolonged hypoglycemia o Insulin overdose o Insulinoma Decreased albumin (dog) or total protein (cat) Hyperthyroidism Uncommon Causes Increased serum triglycerides Azotemia Sample handling – storage at room temperature Related Findings Prolonged hypoglycemia o Insulinoma . Normal to increased serum insulin with concurrent decreased blood glucose . Increased insulin:glucose ratio . Pancreatic mass may be seen on ultrasound (cats>dogs) . A decreased fructosamine is not diagnostic for insulinoma but can increase clinical suspicion Hyperthyroidism o Increased T4, free T4 and free T4 by equilibrium dialysis Increased Fructosamine Common Causes Diabetes Mellitus Hemolysis (certain methodologies) Insulin overdose with Somogyi rebound effect Uncommon Causes Hypothyroidism Increased albumin (dog) or total protein (cat) Related Findings Diabetes Mellitus o Increased blood glucose o Glucose in urine +/- ketones Generated by VetConnect® PLUS: Fructosamine Page 1 of 2 Additional Information Physiology Fructosamine correlates with the patient’s average blood glucose concentration over the last 2-3 weeks. o Fructosamine is not affected by short-term increases in serum glucose such as those that occur with excitement, stress or intravenous dextrose administration. Fructosamine is a ketoamine that is formed by an irreversible, nonenzymatic linking of glucose to proteins (most often albumin and IgG). o Formation of fructosamine is related to the degree and duration of hyperglycemia. o Removal of fructosamine from the blood is dependent on the loss or degradation of the parent molecule (albumin).
    [Show full text]
  • Fructosamine Is a Valuable Marker for Glycemic Control And
    www.nature.com/scientificreports OPEN Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation Noam Shohat1,2, Karan Goswami1, Leigham Breckenridge1, Michael B. Held3, Arthur L. Malkani4, Roshan P. Shah3, Ran Schwarzkopf5 & Javad Parvizi1* Recently, fructosamine has shown promising results in predicting adverse outcomes following total knee arthroplasty. The purpose of this study was to assess the utility of fructosamine to predict adverse outcomes following total hip arthroplasty (THA). A prospective multi‑center study involving four institutions was conducted. All primary THA were evaluated for glycemic control using fructosamine levels prior to surgery. Adverse outcomes were assessed at a minimum 1 year from surgery. Primary outcome of interest was periprosthetic joint infection (PJI) based on the International Consensus Meeting (ICM) criteria. Secondary outcomes assessed were superfcial infections, readmissions and death. Based on previous studies on the subject, fructosamine levels above 293 µmol/L were used to defne inadequate glycemic control. Overall 1212 patients were enrolled in the present study and were available for follow up at a minimum 1 year from surgery. Of those, 54 patients (4.5%) had elevated fructosamine levels (> 293 µmol/L) and these patients were 6.7 times more likely to develop PJI compared to patients with fructosamine levels below 293 µmol/L (p = 0.002). Patients with elevated fructosamine were also associated with more readmissions (16.7% vs. 4.4%, p < 0.007) and a higher mortality rate (3.7% vs. 0.6%, p = 0.057). These associations remained statistically signifcant in a multi‑regression analysis after adjusting for age, comorbidities and length of stay; Adjusted odds ratio were 6.37 (95% confdence interval 1.98–20.49, p = 0.002) for PJI and 2.68 (95% confdence interval 1.14–6.29, p = 0.023) for readmissions.
    [Show full text]
  • Hypoglycemia: ADULT Management Protocol Reference #: SYS-PC-DEG-001.PR1
    System-wide PROTOCOL: Hypoglycemia: ADULT Management Protocol Reference #: SYS-PC-DEG-001.PR1 Origination Date: 3/2012 Revised Date: Next Review Date: 3/2015 Effective Date: 3/2013 Approval Date: 4/2012 Approved By: Diabetes Expert Group System-Wide Protocol Ownership Group: Diabetes Expert Group System Protocol Information Resource: Diabetes Clinical Nurse Specialist SCOPE: Sites, Facilities, Departments, People applicable to Business Units Divisions, Operational (Physicians, NP, Areas Administration, Contractors etc.) All Hospitals, Hospital-wide, excluding Registered Nurses, Licensed Rehabilitation Center newborns and pediatrics Practical Nurses (Inpatient) Be sure to paste the table of this protocol into the progress notes section of the patient’s medical record. This protocol may be implemented without a physician’s order per policy Hypoglycemia: Adult Management Policy #: SYS-PC-DEG-001 EXCEPTION: See insulin infusion protocols for instructions for treatment and management of hypoglycemia. ASSESSMENT: Signs and symptoms of hypoglycemia could include the following: Sweating Rapid heart rate Facial pallor Headache Shakiness/Tremors Tingling around mouth and tongue Increased appetite Change in Level of Consciousness Nausea (ranging from confusion to coma) Dizziness or light-headedness Seizures Sleepiness Weakness In any suspected hypoglycemia situation, obtain a STAT finger stick blood glucose level. Treatment should be initiated prior to obtaining finger stick blood glucose if patient’s symptoms warrant treatment. 1 TREATMENT/INTERVENTIONS: If patient on a SUBCUTANEOUS INSULIN PUMP becomes hypoglycemic, Suspend the insulin pump until blood glucose>60 mg/dL. If patient has a change in level of consciousness (ranging from confusion to coma), pull out infusion site to stop insulin administration if unable to suspend infusion pump.
    [Show full text]
  • Type 1 Diabetes Treatment Guideline | Kaiser Permanente Washington
    Type 1 Diabetes Treatment Guideline Interim Update September 2021 .................................................................................................................. 2 Changes as of March 2021 .......................................................................................................................... 2 Prevention .................................................................................................................................................... 2 Screening ..................................................................................................................................................... 2 Diagnosis...................................................................................................................................................... 2 Treatment ..................................................................................................................................................... 3 Risk-reduction goals ................................................................................................................................ 3 Glucose control goals .............................................................................................................................. 3 Lifestyle modifications and non-pharmacologic options ......................................................................... 4 Pharmacologic options for blood glucose control ................................................................................... 5 Pharmacologic
    [Show full text]
  • High Blood Pressure and Diabetespdf
    High blood pressure and diabetes Why is controlling blood What is high blood pressure (hypertension)? pressure important for Blood pressure is a measurement of the force of your blood against the people with diabetes? blood vessel walls. The recommended target for people with diabetes is less than 130/80 mm Hg. The top number is the pressure when your When blood pressure is high, it puts heart contracts and pushes blood out (systolic). The bottom number is the stress on the body. This can cause pressure when the heart relaxes between beats (diastolic). damage to the heart, brain, kidneys, and eyes. High blood sugar levels There are often no signs of high blood pressure. This means that you may are a risk factor for high blood have high blood pressure and not know it. pressure (hypertension). Compared to people without diabetes, people with diabetes are much more likely Am I doing all that I can to develop heart disease and/or to control my blood pressure? experience a stroke at an earlier age. Yes No People with diabetes should have their blood pressure checked every Do I have my blood pressure checked every time I £ £ time they visit their health-care visit my health-care team? team. Am I at a healthy weight? £ £ Do I follow a healthy diet that includes vegetables, £ £ fruits, low-fat dairy products, and is low in sodium and saturated and trans fats? Am I physically active on a regular basis? £ £ Am I a non-smoker? £ £ Do I manage stress in a healthy way? £ £ Do I limit my alcohol intake? £ £ Do I take my medication as prescribed? £ £ Strategies to lower blood pressure Healthy eating Do the DASH!1 Healthy eating plays an important role in Dietary Approaches to Stop Hypertension, or ‘DASH’ has been managing blood pressure.
    [Show full text]
  • Documenting Diabetes Mellitus Under Icd-10
    DOCUMENTING DIABETES MELLITUS UNDER ICD-10 In ICD-10, diabetes mellitus falls into five major categories. Three Although your patient may have Type 2 diabetes mellitus with- of these categories are rarely encountered in family medicine: out complications (E11.9), the patient may have elevated blood sugars or an elevated A1C. In this situation, it might be more • E08, “Diabetes due to underlying condition,” is never used accurate to code Type 2 diabetes mellitus with hyperglycemia as a primary diagnosis. This category is reserved for indi- (E11.65). ICD-10 does not currently define hyperglycemia, but it viduals who develop diabetes mellitus as the result of an considers hyperglycemia to be a complication of diabetes, which underlying condition such as malignancy, malnutrition, and is why code E11.65 is found in the E11.6 code family for “Type 2 pancreatitis. diabetes mellitus with other specified complications.” Of course, • E09, “Drug or chemical induced diabetes mellitus,” will diabetes with a complication code carries a relatively higher ill- not be encountered often in primary care. When it is, the ness burden than diabetes without a complication code. provider would first code the poisoning due to a drug or Unfortunately, until the final version of ICD-10 is published, it is toxin, use additional codes for adverse effects when appli- unknown whether the term “hyperglycemia” will be defined. cable, and use the fourth through seventh characters to list complications. 3. Specify insulin use. • E13, “Other specified diabetes mellitus,” is another cat- The primary codes for diabetes mellitus do not include whether egory that is rarely used in primary care.
    [Show full text]